Transcatheter aortic valve replacement in very severe aortic stenosis: a systematic review and meta-analysis

Patients with very severe aortic stenosis (VSAS) are regarded to carry a poorer prognosis than patients with severe aortic stenosis (SAS). While current guidelines endorse earlier aortic valve replacement, evidence supporting the safety and efficacy of transcatheter aortic valve replacement (TAVR) in this subgroup remains limited. This systematic review and meta-analysis aimed to clarify clinical outcomes following TAVR in VSAS patients. From inception to March 2025, we systematically searched Medline, Embase, Scopus and Cochrane databases, for studies comparing TAVR outcomes in SAS and VSAS. Primary endpoints included 1-year all-cause mortality and heart failure hospitalizations. Secondary endpoints included procedural complications, and 30-day outcomes. Five observational studies including 2,430 patients (1,724 with SAS and 706 with VSAS) were analyzed. The mean age was 82.4 years, with 64.5% female. VSAS was associated with lower 1-year all-cause mortality (OR = 0.73; 95% CI: 0.57–0.94) and heart failure readmissions (OR = 0.57; 95% CI: 0.36–0.92). Stroke risk trended higher in VSAS (OR = 1.72; 95% CI: 0.87–3.40), while pacemaker implantation rates, degree of paravalvular leak, and 30-day mortality were comparable. Patients with VSAS demonstrate greater benefit in terms of 1-year all-cause mortality and heart failure readmissions after TAVR compared to those with SAS, without an associated increase in procedural complications. Prospective studies with extended follow-up are required to validate these observations.

Authors

Institutions

Publication Details

Journal
BMC Cardiovascular Disorders
Published
2026-11-19
DOI
https://doi.org/10.1186/s12872-026-06790-w
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Transcatheter aortic valve replacement in very severe aortic stenosis: a systematic review and meta-analysis

Amir Yahav, Yuval Avidan, Amir Aker, Hussein Sliman et al.
BMC Cardiovascular Disorders
Cardiac Valve Diseases and Treatments
article

Transcatheter aortic valve replacement in very severe aortic stenosis: a systematic review and meta-analysis

Amir Yahav, Yuval Avidan, Amir Aker, Hussein Sliman, Moataz Tarabih, Salim Adawi, Hadi Fowaz, Sewar Nassar, Hisham Atwan
article en

Abstract

Patients with very severe aortic stenosis (VSAS) are regarded to carry a poorer prognosis than patients with severe aortic stenosis (SAS). While current guidelines endorse earlier aortic valve replacement, evidence supporting the safety and efficacy of transcatheter aortic valve replacement (TAVR) in this subgroup remains limited. This systematic review and meta-analysis aimed to clarify clinical outcomes following TAVR in VSAS patients. From inception to March 2025, we systematically searched Medline, Embase, Scopus and Cochrane databases, for studies comparing TAVR outcomes in SAS and VSAS. Primary endpoints included 1-year all-cause mortality and heart failure hospitalizations. Secondary endpoints included procedural complications, and 30-day outcomes. Five observational studies including 2,430 patients (1,724 with SAS and 706 with VSAS) were analyzed. The mean age was 82.4 years, with 64.5% female. VSAS was associated with lower 1-year all-cause mortality (OR = 0.73; 95% CI: 0.57–0.94) and heart failure readmissions (OR = 0.57; 95% CI: 0.36–0.92). Stroke risk trended higher in VSAS (OR = 1.72; 95% CI: 0.87–3.40), while pacemaker implantation rates, degree of paravalvular leak, and 30-day mortality were comparable. Patients with VSAS demonstrate greater benefit in terms of 1-year all-cause mortality and heart failure readmissions after TAVR compared to those with SAS, without an associated increase in procedural complications. Prospective studies with extended follow-up are required to validate these observations.

BMC Cardiovascular Disorders
Technion – Israel Institute of Technology (IL), Carmel Medical Center (IL)
Good health and well-being
Cardiac Valve Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon